UniQure/CSL Set To Launch First Hemophilia B Gene Therapy Next Year At Record Price

With $3.5m Price Tag

 
• By Ayisha Sharma

The firms’ gene therapy Hemgenix has won a US thumbs up for the treatment of hemophilia B and plans are underway for a US launch with a big price tag that experts agree should pay off in the long-term.  

Hands woman hold drop of blood on blue background.
Hemophilia B Is A Rare Clotting Disorder That Mostly Affects Males • Source: Shutterstock

More from New Products

More from Scrip